Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-4-27
pubmed:abstractText
The safety and efficacy of upfront sunitinib, before nephrectomy in metastatic clear cell renal cancer (mCRC), has not been prospectively evaluated.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-10561319, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-11583750, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-11759643, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-16636341, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-17215529, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-17215530, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-17538086, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-18410444, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-18413834, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-18485389, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-18653228, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-18936475, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-19249681, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-19451873, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-19615940, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-19616232, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-19636008, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-19922542, http://linkedlifedata.com/resource/pubmed/commentcorrection/21242586-21278217
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1569-8041
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1041-7
pubmed:meshHeading
pubmed-meshheading:21242586-Adult, pubmed-meshheading:21242586-Aged, pubmed-meshheading:21242586-Antineoplastic Agents, pubmed-meshheading:21242586-Bone Neoplasms, pubmed-meshheading:21242586-Carcinoma, Renal Cell, pubmed-meshheading:21242586-Disease-Free Survival, pubmed-meshheading:21242586-Female, pubmed-meshheading:21242586-Humans, pubmed-meshheading:21242586-Indoles, pubmed-meshheading:21242586-Kaplan-Meier Estimate, pubmed-meshheading:21242586-Kidney Neoplasms, pubmed-meshheading:21242586-Liver Neoplasms, pubmed-meshheading:21242586-Lung Neoplasms, pubmed-meshheading:21242586-Lymphatic Metastasis, pubmed-meshheading:21242586-Male, pubmed-meshheading:21242586-Middle Aged, pubmed-meshheading:21242586-Neoadjuvant Therapy, pubmed-meshheading:21242586-Nephrectomy, pubmed-meshheading:21242586-Prospective Studies, pubmed-meshheading:21242586-Pyrroles, pubmed-meshheading:21242586-Treatment Outcome, pubmed-meshheading:21242586-Tumor Burden
pubmed:year
2011
pubmed:articleTitle
The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer.
pubmed:affiliation
Department of Medical Oncology, St Bartholomew's Hospital.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II